Background: The reasons why microalbuminuria (albuminuria у15 g/min), an expression of a renal microcirculatory abnormality, predicts cardiovascular disease in essential hypertension are unsettled. To test the hypothesis that microalbuminuria represents a marker of subclinical atherosclerosis, we evaluated its association with common carotid artery (CCA) intima media thickness (IMT), a measure of preclinical atherosclerosis and an independent predictor of cardiac and cerebrovascular events, in uncomplicated essential hypertensive individuals. Materials and methods: Albuminuria, ultrasonographic CCA IMT (the mean of six bilateral far wall measurements within 1.5 cm proximally to the flow divider), brachial blood pressure (BP), smoking habits and lipids were evaluated in 136 stage 1-3 untreated essential hypertensive men free of cardiovascular disease. Results: CCA IMT did not differ between normo-(n ‫؍‬ 99) and microalbuminuric (n ‫؍‬ 37) patients. The correlation
Introduction
Microalbuminuria (ie, an abnormal urinary albumin excretion (UAE), in a range not detectable by the usual dipstick methods for urine protein) predicts incident cardiovascular disease (CVD) and all-cause mortality in population studies, a negative prognostic association independent of the conventional cardiovascular risk factors, including hypertension. [1] [2] [3] This behaviour is consistent with a role of increased urine albumin leakage as a marker of underlying atherosclerotic vascular damage, a hypothesis originally formulated to account for the increased incidence of vascular complications in diabetic subjects with incipient nephropathy. 4 The same possibility may also apply to uncomplicated essential hypertension, another clinical condition in which microalbuminuria identifies individuals at high risk of developing morbid events. between CCA IMT and albuminuria was not significant, and the prevalence of microalbuminuria across IMT quartiles was not different. Microalbuminuric patients showed higher systolic BP and that parameter was the only independent correlate in a multivariate logistic regression model including also age, CCA IMT, diastolic BP, lipids and smoking habits as independent variables and microalbuminuria as the dependent one. Conclusion: This cross-sectional study in hypertensive subjects free of cardiovascular disease has shown a dissociation between microalbuminuria and CCA IMT, a surrogate measure of subclinical atherosclerosis, and a parameter linearly related to cardiovascular events. The data do not support the theory of microalbuminuria as a surrogate measure of subclinical atherosclerosis, while confirming the importance of systolic BP levels as an independent correlate of increased albuminuria in essential hypertension. Journal of Human Hypertension (2000) 14, 831-835 albuminuria and subclinical atherosclerosis in essential hypertension, we recruited a large and well screened group of essential hypertensive subjects in whom we measured UAE and common carotid artery (CCA) intima media thickness (IMT), a measure of preclinical atherosclerosis 6 and an independent predictor of cardiac and cerebrovascular events in still healthy individuals. 7, 8 Few studies [9] [10] [11] [12] have addressed that issue in the past with rather inconsistent results and, therefore, this point is worth of further elucidation.
Materials and methods

Subjects
The study was carried out on 136 stage 1-3 uncomplicated essential hypertensive patients (EH) without any evidence of cardiovascular disease, referred to our department for screening and treatment of hypertension and related risk factors. Inclusion criteria required male sex, negative urine dipstick, normal urinary sediment and renal ultrasound, plasma glucose Ͻ7. Clinical screenings consisted of history, physical examination, routine tests, neck and lower limb colour-echo Doppler sonography. Diagnosis of hypertension was based upon casual blood pressure (BP) values greater than 140/90 mm Hg and/or antihypertensive treatment at the first contact, and secondary forms of hypertension were excluded by routine examinations including renal colour-echo Doppler sonography and, if needed, angiography. A total of 110 patients had never taken antihypertensive medications, the remaining were screened after a 4-week drug withdrawal; none had ever been on lipid-lowering drugs. According to institutional guidelines, subjects were aware of the investigational nature of the study and agreed to participate. The study was carried out in accordance with the Declaration of Helsinki and the protocol was approved by the local Ethical Committee.
Experimental procedures
Data collection was completed in each subject over a 2-week period.
IMT determination was performed on the distal CCA within 1.5 cm proximally to the flow divider, measuring the distance from the leading edge of the first echogenic luminal, bright line to the leading edge of the second echogenic line on frozen images as described by Pignoli et al. 13 Determinations (intraindividual variation coefficient: 13%) were made in longitudinal view at the thickest posterior interface free of plaques (defined as a localised echo structure encroaching into the vessel lumen and more than 50% greater than that of neighbouring sites). Three measurements were obtained on each side, excluding arteries in which references were not identifiable, tortuous or calcified. The instrument was a Sonos 2000 (Hewlett Packard, USA) with a linear 7.5 MHz probe, and an axial resolution of 0.1 mm, keeping the probe maximally focused, and setting up gains and image pre-and post-processing options for every single patient and for each ) 96
Means ± s.d., a median and range.
single artery to obtain the best possible image. The operator spent about 20 min for a complete scanning of each subject plus 20 min for the measurements; images were also recorded on SVHS videotapes for off-line re-evaluation if needed. UAE was measured by nephelometry (Behring, Italy; limit of detection: 0.1 mg/dl, interassay variation coefficient: 3.5%) on samples collected from 8.00 pm to 8.00 am during three consecutive days. Sitting BP was measured in the early afternoon by an automated oscillometric device (Diasys Integra, Novacor, France) throughout a 2-h period. Anthropometric measurements (height and weight) were made after each participant had removed his shoes and upper garments. Blood samples were obtained between 8.00 and 9.00 am after an overnight fasting and 15 min of supine rest. Total, high density lipoprotein (HDL) cholesterol and triglycerides were assessed by enzymatic colorimetric techniques (Boehringer-Mannheim, Germany).
Data processing
IMT was the arithmetic mean of six far wall measurements at the right and left CCA. UAE (g/min) was the median of three consecutive overnight collections (median variation coefficient: 25%). Microalbuminuria was defined as UAE у15 g/min in presence of a negative dipstick test for urine protein.
14 Systolic (SBP) and diastolic (DBP) blood pressure values were the mean of at least 10 recordings taken over a 2-h period in the morning. BMI (body weight/squared surface area), low density lipoprotein (LDL) Cholesterol [Total cholesterol − (HDL cholesterol + triglyceride/5)] were calculated from standard formulae. Selfreported cigarette smoking status was dichotomised as active vs non-smokers, without distinction between former-and never smokers.
Statistics
Continuous variables were tested by ANOVA, and categorical parameters by exact trend tests. Log transformation was applied to UAE because of its non-normal distribution. Intraindividual association was evaluated by non-parametric Spearman's rank correlation coefficients (r s ).
The association of microalbuminuria (coded as 0 = normo-, 1 = microalbuminuria) with continuous and categorical covariates was analysed by logistic regression (maximum likelihood method), using a backward stepwise procedure (P-to-remove: Ͻ0.05) to identify the independent regressors. Odds ratios (ORs, ie, the exponentiated regression coefficients) and 95% confidence intervals (CI) were calculated according to standard methods.
Data were reported as mean ± 1 s.d. or median and range in presence of skewed data. Statistical significance was set at P Ͻ 0.05.
Results
Microalbuminuric patients (median UAE: 25, 15-129 g/min, n = 37) showed higher SBP and greater Figure 1 Lack of difference in CCA IMT between subjects with normo-(n = 99) and microalbuminuria (UAE у15 g/min, n = 37). To provide adequate information about the skewed data distribution, results are presented as Box-and-Whisker plots. The central box encloses the middle 50% of the data; the horizontal line inside the box represents the median and the mean is plotted as a cross. Vertical lines (whiskers) extend from each end of the box and cover four interquartile ranges. Points reports outliers. 26.4 ± 2.5 27.7 ± 3.4* Means ± s.d., a median and range. *P = 0.02, **P Ͻ 0.001. BMI than normoalbuminurics (median UAE: 6, 2-14.8 g/min, n = 99). CCA IMT (Figure 1) , age, DBP, lipids and smoking habits did not differ significantly ( Table 2) .
The prevalence of microalbuminuria across CCA IMT quartiles did not differ (P for trend = 0.25, Figure 2a ) and the intraindividual correlation of UAE correlated with SBP (r s = 0.31, P Ͻ 0.001); BMI (r s = 0.15, P = 0.07), DBP (r s = 0.14, P = 0.08), age (r s = 0.12, P = 0.14), LDL (r s = 0.11, P = 0.2), HDL (r s = 0.09, P = 0.3) cholesterol and triglycerides (r s = −0.03, P = 0.7) were unrelated parameters.
CCA IMT was strongly associated with age (r s = 0.46, P = 0.001), and, to a lesser extent, HDL cholesterol (inversely, r s = −0.19, P = 0.03) and SBP (r s = 0.18, P = 0.04).
A multivariate backward logistic regression model including age, systolic and diastolic BP, BMI and HDL cholesterol identified only SBP (OR/10 mm Hg increase: 1.32, 95% CI: 1.05-1.59, P = 0.013) as a parameter independently associated with microalbuminuria. Forcing CCA IMT into the model was did not change the trend.
Discussion
This cross-sectional study in essential hypertensive subjects free from associated cardiovascular disease has shown a dissociation between microalbuminuria and CCA IMT, a surrogate measure of subclinical atherosclerosis, 6 and a parameter gradedly and linearly related to cardiovascular events in subjects still healthy at baseline. 7, 8 Other data in the literature support our conclusions. Agewall et al, 9 for example, reported a similar dissociation in a non-diabetic hypertensive group with one or more cardiovascular risk factors, while a statistically significant association of urine albumin with common carotid thickness in the non diabetic members of the IRAS cohort became non-significant after adjustment for hypertension. 11 In contrast, other authors 10, 12 reported thicker common carotid walls in essential hypertensive patients with microalbuminuria. The discrepancy cannot explained by insufficient statistical power since ex-post calculations showed that our sample size (99 normo-vs 37 microalbuminuric patients) could exclude safely (␤ Ͻ 0.20) differences equal or greater than 0.08 mm, ie, similar to those reported in the above studies. 10, 12 Gender-related phenomena may perhaps contribute since we included only males, and it might also be worth of comment the unusual absence in the same studies 10, 12 of any trend to higher pressure values in microalbuminuric subjects. That common pattern
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(see reference 15 for a review) 15 emerged quite clearly in our sample with particular regard to systolic BP, the only parameter independently associated with microalbuminuria in a stepwise multivariate logistic model including age, lipids, smoking habits and BMI in addition to CCA IMT, while DBP played no role. The preferential association of the systolic load with urine albumin levels has already been reported in cross-sectional 16 and prospective 17, 18 population-based investigations, and is also consistent with the epidemiologic evidence about the risk factors for renal disease. 19 The data might express the contribution of purely hydraulic factors to subclinical renal damage 20 but cross-sectional associations are to be taken with caution. In fact, these same results are compatible with exactly opposite interpretations, eg, an effect of urine albumin on SBP, or even represent the role of third factors acting on both variables. Furthermore, it should be considered the nature of microalbuminuria as an integrated cardiovascular risk marker responsive to a wide array of cardiovascular risk factors and atherogenic mechanisms additional to BP levels. Independent associations have been found with left ventricular hypertrophy, 21 cigarette smoking, 16 and, according to some investigators, hyperlipidaemia, hyperinsulinaemia and insulin resistance. 22 However, additional still unknown albuminuric factors may very likely exist.
The present data do not support the theory of increased urine albumin levels as a surrogate marker of subclinical atherosclerosis in uncomplicated essential hypertension. 4 The same negative conclusion was reached in studies carried out in hypertensive and atherosclerotic patients, 23 and in prospective observations reporting unchanged cardiovascular risk estimates after mutual adjustment for microalbuminuria and peripheral arterial disease. 2 Some limitations exist, however. First, hypertensive medial wall hypertrophy may coexist with intimal thickening, 24 making less precise the detection of atherosclerotic involvement at the common carotid level, a limit that the current sonographic techniques cannot overcome. Second, the overwhelming haemodynamic impact in hypertension may hide any direct modulating influence of vascular status, and, for this reason, studies in normotensive subjects might be more useful, although previous reports have shown normal UAE in normotensive subjects with advanced atherosclerotic disease. 25, 26 Third, the pathogenetic backgrounds of microalbuminuria in hypertension may differ from diabetes, the two clinical conditions most strongly associated with increased UAE in populations at large, 27 since UAE was an independent correlate of CCA IMT in diabetic patients. 9, 11 Finally, one might still contend that elevated SBP is more sensitive than CCA IMT as a surrogate measure of subclinical atherosclerosis disease. SBP elevation, in fact, correlates with the extent of arteriosclerotic degeneration of large arteries, 28 carotid atherosclerosis progression 29 and cardiovascular complications. 30 It is also important to discuss in this same context the relationship of microalbuminuria and endothelial function, a parameter frequently abnormal in essential hypertension, that may precede and accelerate atherosclerotic progression. 31 On one hand, consistent evidence does suggest that hypertensive microalbuminuria is associated with circulating markers of endothelial dysfunction, [32] [33] [34] [35] including von Willebrand Factor, an endothelial haemostatic factor and a predictor of cardiovascular death. 36 On the other hand, however, urine albumin was dissociated from both the transcapillary 125 I-albumin escape rate, a measure of systemic capillary permeability, 28, 37 and forearm vasodilatation to acetylcholine, 38 a compound that releases nitric-oxide from endothelial cells. 31 Thus, microalbuminuria may not reflect defects of specific endothelial functions such as macromolecular permeability 39 and nitric-oxide release, 31 but rather represent a non-specific response to inflammatory stimuli, in itself a cardiovascular risk factor. 40 The hypothesis is supported by the acute and prognostically relevant UAE increments after myocardial infarction, 41 a condition accompanied by a prominent inflammatory reaction, 40 and is consistent with the positive correlation with circulating soluble vascular cell adhesion molecule (VCAM)-1, a protein expressed on the surface of activated endothelial cells. 42 Further studies are therefore needed to address the mechanisms by which microalbuminuria increases the risk of cardiovascular disease in essential hypertension.
